Literature DB >> 9531273

Purified MHC class I and peptide complexes activate naive CD8+ T cells independently of the CD28/B7 and LFA-1/ICAM-1 costimulatory interactions.

J S Goldstein1, T Chen, M Brunswick, H Mostowsky, S Kozlowski.   

Abstract

T cells play a central role in the initiation, maintenance, and regulation of the immune response. Effector responses of T cells are controlled by complex combinations of lymphokines and adhesion/costimulatory molecule signals. To isolate the effects of specific adhesion/costimulatory molecules and to define the minimal molecular requirements of naive CD8+ T cell activation, we have developed an APC-free system for stimulation of naive CD8+ T cells. In this report, we demonstrate that immobilized MHC class I-peptide complexes can activate naive CD8+ T cells from TCR transgenic mice at low cell densities. The CD8+ T cells were stimulated to proliferate and secrete IL-2 independently of the molecular interactions between CD28/B7.1-B7.2 or LFA-1/ICAM-1 surface receptors. Previous reports have shown that CD28 ligation is necessary for late T cell survival of APC-stimulated naive CD8+ T cells. Our data suggest that under certain specific conditions of high intensity T cell signaling, early activation and late cell proliferation can occur independently of APC-derived costimulatory signals.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9531273

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection.

Authors:  J Trambley; A W Bingaman; A Lin; E T Elwood; S Y Waitze; J Ha; M M Durham; M Corbascio; S R Cowan; T C Pearson; C P Larsen
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

2.  Major histocompatibility complex class II- fetal skin dendritic cells are potent accessory cells of polyclonal T-cell responses.

Authors:  A Elbe-Bürger; A M Mommaas; E E Prieschl; E Fiebiger; T Baumruker; G Stingl
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

3.  A transgenic mouse model to analyze CD8(+) effector T cell differentiation in vivo.

Authors:  N Manjunath; P Shankar; B Stockton; P D Dubey; J Lieberman; U H von Andrian
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

4.  Granulocyte-macrophage colony-stimulating factor drives monocytes to CD14low CD83+ DCSIGN- interleukin-10-producing myeloid cells with differential effects on T-cell subsets.

Authors:  Dipyaman Ganguly; Kausik Paul; Jayashree Bagchi; Srabanti Rakshit; Labanya Mandal; Gautam Bandyopadhyay; Santu Bandyopadhyay
Journal:  Immunology       Date:  2007-04-13       Impact factor: 7.397

5.  Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells.

Authors:  Shahram Salek-Ardakani; Ramon Arens; Rachel Flynn; Alessandro Sette; Stephen P Schoenberger; Michael Croft
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

6.  Differential graft-versus-leukaemia effect by CD28 and CD40 co-stimulatory blockade after graft-versus-host disease prophylaxis.

Authors:  J Ohata; J Sakurai; K Saito; K Tani; S Asano; M Azuma
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

Review 7.  Soluble MHC class I complexes for targeted immunotherapy.

Authors:  Anna Schappert; Jonathan P Schneck; Lauren Suarez; Mathias Oelke; Christian Schütz
Journal:  Life Sci       Date:  2018-08-10       Impact factor: 5.037

8.  Antigen-specific signaling by a soluble, dimeric peptide/major histocompatibility complex class II/Fc chimera leading to T helper cell type 2 differentiation.

Authors:  S Casares; C S Zong; D L Radu; A Miller; C A Bona; T D Brumeanu
Journal:  J Exp Med       Date:  1999-08-16       Impact factor: 14.307

9.  MHC-Ig induces memory T cell formation in vivo and inhibits tumour growth.

Authors:  Christian Schütz; Alessia Zoso; Shiwen Peng; Jonathon D Bennett; Jonathan P Schneck; Mathias Oelke
Journal:  Immun Inflamm Dis       Date:  2014-11-11

10.  CD28 costimulation is required for in vivo induction of peripheral tolerance in CD8 T cells.

Authors:  Melanie S Vacchio; Richard J Hodes
Journal:  J Exp Med       Date:  2003-01-06       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.